Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
Phase I trial of CC-8490 for the treatment of subjects with recurrent/refractory high-grade gliomas
Glioblastoma|Malignant Gliomas
DRUG: CC-8490
Phase I trial of CC-8490 for the treatment of subjects with recurrent/refractory high-grade gliomas